When evaluating a PBM contract at renewal or mid-term market check, brokers and plan sponsors should be asking questions. Questions that...

Americans spent $328 billion on prescription drugs in 2020, eight percent of total healthcare spend. The rising cost of medications is...

Research on gene-therapies began in 1960 with the hypothesis that introducing DNA sequences into patients' cells could cure genetic...

High-cost prescription drugs have been wreaking havoc on pharmacy plan budgets for over a decade. However, did you know that drugs costs...

This year saw a post-pandemic return to preventive care, the introduction of several biosimilars, and legislation governing healthcare...

By identifying data and vendor silos that affect participant engagement and spend, payors and brokers can begin to build better benefits.

With its unique set of challenges, the pharmacy industry is already benefiting from AI-powered technology;

For self-insured plan sponsors, specialty drugs represent 33-50% of total pharmacy spend but only account for 1% of total prescription...

It is not surprising that there is little transparency around the factors influencing formulary development—chief among those: rebates.

The proven efficacy, safety, and cost savings of biosimilars make them a valuable weapon in the fight for more access to lower-cost

When paired with proactive participant engagement, data analytics can help plan sponsors improve medication adherence.

60% of employers report that the cost of their current pharmacy plan is unsustainable. Without requesting bids from vendors or...

A clinically-driven, value-based pharmacy model moves the plan toward the lowest net cost.

This year has been, in a word, unique. Fortunately, time marches on, and a new year is around the corner. This article looks forward to...

There are six significant stakeholders in the complex drug distribution system: pharmaceutical manufacturer, plan sponsor, pharmacy, PBM,...

The cost of prescription medications is rising, but one sub-set of drugs may be disproportionately eating away at financial resources....

In the pharmacy space, industry leaders are embracing data analytics to distance themselves from the competition and provide top-level benef

As some states lift stay-at-home orders amid growing numbers of COVID-19 cases, scientists worldwide are working on potential treatments...

Even before COVID-19 wreaked havoc on the United States’ healthcare system, the availability and price of prescription drugs were a...

The severe state of emergency facing our global community has resulted in many of us staying home in a united effort to stop the spread...